Workflow
Earnings ESP
icon
Search documents
Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth
ZACKSยท 2025-07-28 15:06
Hims & Hers Health, Inc. (HIMS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
ZACKSยท 2025-07-28 15:06
Wall Street expects a year-over-year decline in earnings on higher revenues when Inspire Medical Systems (INSP) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 4, might help the stock move higher if these key numbers are better than e ...
JBT Marel (JBTM) Reports Next Week: Wall Street Expects Earnings Growth
ZACKSยท 2025-07-28 15:06
Company Overview - JBT Marel (JBTM) is expected to report a year-over-year increase in earnings, with a projected EPS of $1.27, reflecting a +21% change, and revenues anticipated at $898.77 million, which is up 123.4% from the previous year [3][12]. Earnings Expectations - The consensus EPS estimate has been revised 9.29% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The upcoming earnings report is scheduled for August 4, and the stock may react positively if the actual results exceed expectations [2][12]. Earnings Surprise Prediction - JBT has an Earnings ESP of +0.59%, suggesting a likelihood of beating the consensus EPS estimate [12]. - The company holds a Zacks Rank of 2 (Buy), which, when combined with a positive Earnings ESP, increases the probability of an earnings surprise [10][12]. Historical Performance - In the last reported quarter, JBT exceeded the expected EPS of $0.82 by delivering $0.97, resulting in a surprise of +18.29% [13]. - Over the past four quarters, JBT has beaten consensus EPS estimates two times [14]. Industry Comparison - Mirion Technologies, another player in the Zacks Technology Services industry, is expected to report an EPS of $0.1, indicating no change from the previous year, with revenues projected at $213.9 million, up 3.3% [18]. - Mirion Technologies has an Earnings ESP of 0% and a Zacks Rank of 2 (Buy), making it challenging to predict an earnings beat [19].
Earnings Preview: Ardelyx (ARDX) Q2 Earnings Expected to Decline
ZACKSยท 2025-07-28 15:06
Company Overview - Ardelyx (ARDX) is expected to report a year-over-year decline in earnings despite higher revenues for the quarter ended June 2025, with a consensus outlook indicating a quarterly loss of $0.13 per share, representing an 85.7% decrease from the previous year [1][3] - Revenues are projected to be $84.64 million, reflecting a 15.6% increase compared to the same quarter last year [3] Earnings Expectations - The earnings report is anticipated to be released on August 4, and the stock may experience upward movement if the reported numbers exceed expectations; conversely, a miss could lead to a decline in stock price [2] - The consensus EPS estimate has been revised down by 6.25% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4] Earnings Surprise Prediction - The Most Accurate Estimate for Ardelyx is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -6.18%, which suggests a bearish outlook from analysts [12] - The company currently holds a Zacks Rank of 4, making it challenging to predict a beat on the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Ardelyx was expected to post a loss of $0.10 per share but actually reported a loss of $0.17, resulting in a surprise of -70.00% [13] - Over the past four quarters, Ardelyx has beaten consensus EPS estimates two times [14] Industry Comparison - In the Zacks Medical - Drugs industry, United Therapeutics (UTHR) is expected to report earnings of $6.8 per share for the same quarter, indicating a year-over-year increase of 16.2% [18] - United Therapeutics' revenue is projected to be $795.75 million, up 11.3% from the previous year, with a revised consensus EPS estimate down by 2.4% over the last 30 days but an Earnings ESP of +7.09% [19][20]
Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth
ZACKSยท 2025-07-28 15:06
Wall Street expects a year-over-year increase in earnings on higher revenues when Krystal Biotech, Inc. (KRYS) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the sto ...
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?
ZACKSยท 2025-07-28 15:06
The market expects Palantir Technologies Inc. (PLTR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 4, might help the stock move higher if these key numbe ...
Palomar (PLMR) Earnings Expected to Grow: Should You Buy?
ZACKSยท 2025-07-28 15:06
Wall Street expects a year-over-year increase in earnings on higher revenues when Palomar (PLMR) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may mo ...
Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for
ZACKSยท 2025-07-28 15:06
Core Viewpoint - SiriusPoint (SPNT) is anticipated to report a year-over-year decline in earnings due to lower revenues, with earnings expected to be $0.56 per share, reflecting a -1.8% change, and revenues projected at $720.1 million, down 3.1% from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for August 4, and the stock may experience price movement based on whether the reported numbers exceed or fall short of expectations [2]. - The consensus EPS estimate has been revised down by 14.12% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that SiriusPoint has an Earnings ESP of 0%, suggesting no recent analyst revisions that differ from the consensus estimate [12]. - Despite a Zacks Rank of 2 (Buy), the combination of a 0% Earnings ESP makes it challenging to predict an earnings beat for SiriusPoint [12]. Historical Performance - In the last reported quarter, SiriusPoint had an earnings surprise of +88.46%, reporting $0.49 per share against an expected $0.26 [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Comparison - In contrast, MGIC Investment (MTG), another player in the insurance industry, is expected to post earnings of $0.7 per share, reflecting a -9.1% year-over-year change, with revenues projected at $306.76 million, up 0.4% [18][19]. - MGIC has an Earnings ESP of +2.37% and has consistently beaten consensus EPS estimates in the last four quarters, indicating a more favorable outlook compared to SiriusPoint [19].
Earnings Preview: Trex (TREX) Q2 Earnings Expected to Decline
ZACKSยท 2025-07-28 15:06
Core Viewpoint - Trex (TREX) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending June 2025, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The consensus estimate for Trex's quarterly earnings is $0.71 per share, reflecting an 11.3% decrease year-over-year. Revenues are projected to be $377.91 million, which is a 0.4% increase from the same quarter last year [3]. Estimate Revisions - Over the past 30 days, the consensus EPS estimate has been revised 0.95% higher, indicating a collective reassessment by analysts regarding the company's earnings outlook [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Trex's Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.07%, suggesting a bearish sentiment among analysts [12]. Historical Performance - Trex has a history of beating consensus EPS estimates, having done so in the last four quarters. In the most recent quarter, it reported earnings of $0.60 per share against an expectation of $0.58, achieving a surprise of +3.45% [13][14]. Investment Considerations - While Trex does not appear to be a strong candidate for an earnings beat, investors are advised to consider other factors that may influence stock performance ahead of the earnings release [17].
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
ZACKSยท 2025-07-28 15:06
The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be ...